The Canadian Nurses Association (CNA) is offering a 5-part series on Substance use trends in Canada: What nurses need to know.
Substance use trends in Canada: What nurses need to know — A five-part series Join this series and hear nurse experts discuss some of today’s key questions regarding substance use. What roles are nurses playing to prevent and respond to these complex health issues? Learn more about nursing approaches, the nurse-client relationship and how to address the substance use stigma. The five webinars will examine:
- Opioid overdose prevention basics for nurses - March 7th
- An evidence-based review of opioid agonist treatments and what they mean for nursing practice - April 4th
- Supervised consumption sites: Where are we now? May 2nd
- Creating safe spaces in health care for people who use May 30th
- Cannabis in Canada: Implications for nursing in a changing legal and health-care landscape - June 27th
Cannabis in Canada: Implications for nursing in a changing legal and health-care landscape
Tuesday, June 27, 2017 1:30 PM - 2:30 PM
The use of cannabis both recreationally and medically has shifted significantly in Canada. New legislation, a growing body of research, and changing attitudes towards cannabis as a controlled substance all have an impact on nursing.
Register for this free webinar to:
- Discover recent policy changes
- Learn the risks and benefits of cannabis use
- Explore the stigma surrounding cannabis in the context of health care and Canadian society
- Understand the implications for nursing with regards to balancing the risks of recreational cannabis with the potential benefits of medical cannabis
Presented by: Lynda Balneaves, RN, PhD
Lynda Balneaves is an associate professor in the University of Manitoba’s college of nursing. For the past 20 years she has focused her research on supporting informed treatment decisions in people living with cancer interested in using complementary therapies. Balneaves is the the principal investigator of the Complementary Medicine Education and Outcomes (CAMEO) research program, which has developed and evaluated a variety of education and decision support interventions aimed at helping cancer patients and health professionals make evidence-informed decisions about complementary therapies. She has also conducted health services and policy research on the use of medical cannabis in Canada. Currently, Balneaves is the president-elect of the Society for Integrative Oncology and is board member for the International Society for Complementary Medicine Research organization. She has received the Canadian Cancer Society Research Scientist Award and the CIHR New Investigator Award.